RPI.4610

· Ribozyome

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RPI.4610, covering 2013-03-26 to 2013-03-26. Get the full timeline:

Most recent: Clinical Trial Update: RPI.4610 in Treating Patients With Metastatic Kidney Cancer [Phase 2]